Maria Sfakianaki

Evaluation of global simulations of aerosol particle and cloud condensation nuclei number, with implications for cloud droplet formation

George S. Fanourgakis, Maria Kanakidou, Athanasios Nenes et al. · Atmospheric chemistry and physics · 2019 · 138 citations · Full text

Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥2nd Line Cetuximab-Based Therapy of Colorectal Cancer Patients

Zacharenia Saridaki, Maria Tzardi, Chara Papadaki et al. · PLoS ONE · 2011 · 124 citations · Full text

ERCC1 and BRAC1 mRNA Expression Levels in the Primary Tumor Could Predict the Effectiveness of the Second-Line Cisplatin-Based Chemotherapy in Pretreated Patients with Metastatic Non-small Cell Lung Cancer

Chara Papadaki, Maria Sfakianaki, Georgios Ioannidis et al. · Journal of Thoracic Oncology · 2012 · 70 citations

Pretreated Patients, Second-line Cisplatin-based Chemotherapy, Medicine +7

PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer

Chara Papadaki, Maria Sfakianaki, Eleni Lagoudaki et al. · British Journal of Cancer · 2014 · 58 citations · Full text

Prognostic Value of KRAS Mutations in Colorectal Cancer Patients

Asimina Koulouridi, Michaela Karagianni, Ippokratis Messaritakis et al. · Cancers · 2022 · 57 citations · Full text